Pre-surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60%

Sponsor
Centro Ortopedico y Quirurgico del Pie (Other)
Overall Status
Completed
CT.gov ID
NCT04538365
Collaborator
(none)
24
1
2
29
25.2

Study Details

Study Description

Brief Summary

The present study evaluates the effects of bactericidal load reduction after surgical hand scrub antisepsis using the reference antiseptic product propanol-

1 60% as control versus a surgical hand scrub antisepsis with triclosan 0.5% in order to test if pass the standard european norm 12791.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

The investigators conducted a crossover clinical trial to evaluate the antiseptic effectiveness of preoperative surgical scrubbing using propan-ol-1 60% by scrub using the reference antiseptic product propan-ol-1 60% as control versus a surgical hand scrub antisepsis with trocilosan 0.5% in order to test if pass the standard european norm 12791. Samples will be taken from the hands of each volunteer after a surgical hands antiseptic.

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Crossover design is usedCrossover design is used
Masking:
Single (Outcomes Assessor)
Masking Description:
The samples will be sent to the laboratory with numbers
Primary Purpose:
Treatment
Official Title:
Effect on the Reduction of Bacterial Load in Surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60% Used as Reference Disinfectant
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
Oct 20, 2020
Actual Study Completion Date :
Oct 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Hand antisepsis with propanolol-1 60%

Effectiveness of pre-surgical hand washing in reducing bacterial load using propanolol-1 60% as control

Drug: propanolol
Hand antisepsis by scrub Surgical Hand scrubbing using Propanolol 60% solution both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side
Other Names:
  • Hand antisepsis with Propanolol 60% solution
  • Experimental: Hand antisepsis with triclosan solution

    Effectiveness of pre-surgical hand washing in reducing bacterial load using triclosan 0.5% solution

    Drug: Triclosan 0.5 % Topical Solution
    Hand antisepsis by scrub Surgical Hand scrubbing using triclosan 0.5% solution both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side
    Other Names:
  • Hand antisepsis with Triclosan 0.5% solution.
  • Outcome Measures

    Primary Outcome Measures

    1. Reduction of bacterial load immediately after hand scrub [Change from bacterial load at 5 minutes]

      Participants will scrub with the antiseptic solution vigorously from hand to the wrists according with the standard handscrub procedure

    Secondary Outcome Measures

    1. Reduction of bacterial load after 3 hours of hand scrub [Change from bacterial load after 3 hours]

      Participants will scrub with the antiseptic solution vigorously from hand to the wrists according with the standard handscrub after 3 hours

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Participants without systemic pathologies, with healthy skin of the hands and short fingernails.

    • They do not use substances with antibacterial action.

    Exclusion Criteria:
    • Taken antibiotics before 10 days of the intervention.

    • Wear any jewellery on the hands

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Facultad de Enfermeria, Fisioterapia y Podologia Madrid Spain 28040

    Sponsors and Collaborators

    • Centro Ortopedico y Quirurgico del Pie

    Investigators

    • Principal Investigator: Ricardo B Becerro de Bengoa Vallejo, PhD, Universidad Complutense de Madrid

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ricardo Becerro de Bengoa Vallejo, Principal Investigator, Centro Ortopedico y Quirurgico del Pie
    ClinicalTrials.gov Identifier:
    NCT04538365
    Other Study ID Numbers:
    • RICBEC1
    First Posted:
    Sep 4, 2020
    Last Update Posted:
    Nov 2, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ricardo Becerro de Bengoa Vallejo, Principal Investigator, Centro Ortopedico y Quirurgico del Pie
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 2, 2020